In addition, in an in vitro model of PG-LPS-induced periodontitis, major ginsenosides demonstrated the effect of controlling EGFR-mediated HO-1 on the inhibitory effect of periodontal inflammation and alveolar bone loss, an important treatment strategy for periodontitis. This evidence concerns the gene EGFR and periodontitis.